Advances by Scientists in Health: Monoclonal Antibodies
Abstract
Advances by Scientists in Health: Monoclonal Antibodies
Downloads
References
1. Arranz Barrio J, Gálligo Andrea L, Gay Fernández E, Aranda Pascual J, Galochino Azores MP, Abad Marín P. Uso de los anticuerpos monoclonales para el tratamiento del cáncer. RSI[Internet]. 2025 [citado 01/10/2025]; VI(8). Disponible en: https://revistasanitariadeinvestigacion.com/uso-de-los-anticuerpos-monoclonales-para-el-tratamiento-del-cancer/
2. Hernández Díaz YE, Ibargollín Ulloa R. Evolución, aplicaciones y perspectivas de los anticuerpos monoclonales. En: III Taller nacional científico metodológico de profesores de la educación médica. EDUCIENCIAPDCL2025[Internet]; 2025(citado 23/08/2025). Disponible en: https://jorcienciapdcl.sld.cu/index.php/EDUCIENCIAPDCL2025/ec2025/paper/view/1110/0
3. Crescioli S, Kaplon H, Wang L, Visweswaraiah J, Kapoor V, Reichert JM. Antibodies to watch in 2025. mAbs[Internet]. 2025(citado 23/08/2025); 17(1). Disponible en: https://doi.org/10.1080/19420862.2024.2443538
4. Justiz-Vaillant A, Pandit BR, Unakal C, Vuma S, Akpaka PE. Una revisión integral sobre el uso de anticuerpos monoclonales en el tratamiento del cáncer. Anticuerpos[Internet]. 2025(citado 23/08/2025); 14(2): 35. Disponible en: https://doi.org/10.3390/antib14020035
5. Global Market Insights. Mercado de anticuerpos monoclonales: análisis de la industria [Internet]; 2025 [citado 01/10/2025]. Disponible en: https://www.gminsights.com/es/industry-analysis/monoclonal-antibodies-market
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Eduardo Enrique Cecilia-Paredes

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
